Booz Allen acquires analytics start-up Epidemico

Laura Pedulli | | Health Exec | Digital Transformation

Booz Allen Hamilton has purchased Epidemico, a Boston-based health analytics start-up, for an undisclosed amount, reports The Washington Post.

Epidemico is the creator of HealthMap, an online mapping tool that tracks the spread of diseases using a computer algorithm. It has been credited with tracking Ebola in West Africa before the World Health Organization declared it an outbreak.

Read more below:

Booz Allen buys Boston health analytics start-up Epidemico

Laura Pedulli

Related Content

5 ways to let AI raise patient satisfaction, elevate provider performance
When life sciences met artificial intelligence
AdvaMed itemizes AI imperatives for ‘the entire healthcare ecosystem’
6 things high-achieving orgs do to wring real value from AI
A modest proposal to rally AI regulators around a simple game plan
4 points crucial to the nimble regulation of GenAI

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”